2023 - Research.com Psychology in Canada Leader Award
Boris B. Gorzalka mainly focuses on Internal medicine, Endocrinology, Endocannabinoid system, Neuroscience and Cannabinoid receptor. His Internal medicine study typically links adjacent topics like Pharmacology. His Endocrinology research includes elements of Social aggression and AM251.
He combines subjects such as Chronic stress, Antidepressant, Anandamide, Hippocampus and Corticosterone with his study of Endocannabinoid system. His research in Neuroscience intersects with topics in Animal model and Naloxone. As a part of the same scientific family, Boris B. Gorzalka mostly works in the field of Cannabinoid receptor, focusing on Anxiolytic and, on occasion, Elevated plus maze.
His scientific interests lie mostly in Endocrinology, Internal medicine, Developmental psychology, Endocannabinoid system and Cannabinoid receptor. Boris B. Gorzalka is interested in Corticosterone, which is a field of Endocrinology. His Developmental psychology study integrates concerns from other disciplines, such as Human sexuality, Sexual attraction, Sexual desire, Sexual arousal and Sexual dysfunction.
His biological study spans a wide range of topics, including Hippocampus, Chronic stress, Neuroscience, Prefrontal cortex and Anandamide. His Cannabinoid receptor research is multidisciplinary, relying on both Behavioural despair test and Cannabinoid. The study incorporates disciplines such as Dentate gyrus, Depolarization-induced suppression of inhibition and Pharmacology in addition to Cannabinoid.
Boris B. Gorzalka spends much of his time researching Developmental psychology, Endocannabinoid system, Human sexuality, Clinical psychology and Internal medicine. Boris B. Gorzalka has researched Developmental psychology in several fields, including Sexual attraction, Sexual dysfunction, Acculturation and Sexual desire. His Endocannabinoid system research includes themes of Chronic stress, Neuroscience, Depression, Prefrontal cortex and Cannabinoid receptor.
His Human sexuality research incorporates themes from Eating disorders, Disordered eating, Cognition and Attachment theory. The Clinical psychology study combines topics in areas such as Anxiety, Cognitive distraction and Sexual coercion. Much of his study explores Internal medicine relationship to Endocrinology.
His main research concerns Endocannabinoid system, Internal medicine, Endocrinology, Prefrontal cortex and Neuroscience. His study in Endocannabinoid system is interdisciplinary in nature, drawing from both Neurogenesis, Cognition, Chronic stress and Pharmacology. His studies in Prefrontal cortex integrate themes in fields like Anandamide, Cannabinoid receptor, Hippocampus, Receptor antagonist and Amygdala.
His Cannabinoid receptor research includes elements of Raphe nuclei and Neurotransmission. His work on Depression, Mild stress and Stressor as part of general Neuroscience study is frequently linked to Neurochemistry, bridging the gap between disciplines. His gamma-Aminobutyric acid study incorporates themes from Hippocampal formation, Cannabinoid, Inhibitory postsynaptic potential and Glucocorticoid.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Neurobiology of chronic mild stress: parallels to major depression.
Matthew N. Hill;Kim G.C. Hellemans;Pamela Verma;Boris B. Gorzalka.
Neuroscience & Biobehavioral Reviews (2012)
Downregulation of Endocannabinoid Signaling in the Hippocampus Following Chronic Unpredictable Stress
Matthew N Hill;Sachin Patel;Erica J Carrier;David J Rademacher.
Endogenous cannabinoid signaling is essential for stress adaptation
Matthew N. Hill;Ryan J. McLaughlin;Brenda Bingham;Lalita Shrestha.
Proceedings of the National Academy of Sciences of the United States of America (2010)
Recruitment of prefrontal cortical endocannabinoid signaling by glucocorticoids contributes to termination of the stress response.
Matthew N. Hill;Ryan J. McLaughlin;Bin Pan;Megan L. Fitzgerald.
The Journal of Neuroscience (2011)
Opioids and sexual behavior.
James G. Pfaus;Boris B. Gorzalka.
Neuroscience & Biobehavioral Reviews (1987)
Suppression of Amygdalar Endocannabinoid Signaling by Stress Contributes to Activation of the Hypothalamic–Pituitary–Adrenal Axis
Matthew N Hill;Ryan J McLaughlin;Anna C Morrish;Victor Viau.
Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress
Matthew N. Hill;Gregory E. Miller;Erica J. Carrier;Boris B. Gorzalka.
Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report.
M. N. Hill;G. E. Miller;W.-S. V. Ho;B. B. Gorzalka.
Pharmacological enhancement of cannabinoid CB1 receptor activity elicits an antidepressant-like response in the rat forced swim test
Matthew N. Hill;Boris B. Gorzalka.
European Neuropsychopharmacology (2005)
Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment.
Matthew N. Hill;Erica J. Carrier;Ryan J. McLaughlin;Anna C. Morrish.
Journal of Neurochemistry (2008)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: